Genentech of South San Francisco, Calif. recalled 14,000 bottles of the prescription drug Evrysdi (risdiplam).
The bottles can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes.
This poses a risk of poisoning if the contents are swallowed by toddlers.
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine that is used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older.
The firm has received 26 reports of leaking bottles.
The medication was manufactured in Switzerland and was sold at select specialty pharmacies nationwide as a prescribed medicine.
In response to this, Genentech notified purchasers about the recall. The company urges consumers to immediately store the product in a safe location that is out of reach of children.
The company urges customers to also contact them for a free child-resistant replacement camp.
There have been no reported incidents to date.
© Fourth Estate
® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.